BioFlyte is a biodetection company with a revolutionary new class of fieldable biological threat collection, detection, and identification solutions.
BioFlyte is commercializing a revolutionary new class of fieldable aerosol mass spectrometers and complementary products for protection from biological and low-volatility chemical threats.
BioFlyte was founded in 2020 by Charles Call. The company is headquartered in Albuquerque, New Mexico.
BioFlyte's first product is the z750 handheld collector, designed to provide CBRN Defense Forces and Emergency Response Teams with an advanced high-performance handheld aerosol sampler. The z750 handheld collector is designed around a proven dry filter technology that has been in use worldwide for decades.
The BioTOF z200 is a miniaturized, low-cost, and low-power bio-aerosol detection system for continuous and autonomous operation in critical infrastructure environments such as third-party command control systems and architectures.
BioFlyte is backed by Cottonwood Technology Fund, Scout Ventures, Anzu Partners, New Mexico Vintage Fund, and others. The company raised $5.4M in a Series B round on Aug 10, 2023. This brings BioFlyte's total funding to $12.8M to date.